Lallemand Health Solutions is proud to announce its contribution as scientific partner to the Second International Symposium on Probiotics & Prebiotics in Pediatrics (IS3P) taking place in Antalya, Turkey, March 7 to 9, 2014.
Following the sponsorship of the recent Probiota 2014 conference, this involvement in a pediatric conference marks our commitment to support and promote scientific events dedicated to the advancement of probiotics science and applications. In particular, in Turkey and many other markets, children and infants health represent important fields of application for probiotics, with proven benefits in overall digestive health, diarrhea prevention or immunity.
This symposium is also an opportunity for Lallemand Health Solutions to promote its scientific results and clinical studies in children among local pediatricians. The company has developed several probiotic solutions with proven benefits in children health. The most documented solution in this area is Lacidofil®, a combination of the specific strains Lactobacillus helveticus Rosell-52 and Lactobacillus rhamnosus Rosell-11, supported by numerous preclinical studies and 23 human trials, including many pediatric studies. It is sold in Europe, Asia and North America since 1995 as a food supplement or pharmaceutical, and the company is at present looking for a partner to distribute Lacidofil in Turkey.
The goal of the second IS3P “Reunion of Experts” is to increase the awareness on clinical impact of pro/prebiotics and functional foods in childhood health and disorders. The comprehensive conference program, featuring internationally renowned speakers will ensure the coverage of all issues on the pro/prebiotics, infant formulas and evidence-based benefits of functional foods.